Dr. Ami Greene’s Dermoscopy Mastery: A Deep Dive into Skin Cancer and Lesion Diagnosis
October 27, 2023

Assistant Professor of Dermatology, Mohs surgeon and dermatologist Ami Greene, MD, delivered an enlightening talk for the case based-dermoscopy track on diagnosing common skin cancers and lesions at the SDPA 21st Annual Fall Dermatology Conference.  Dr. Greene kicked off her discussion by polling the audience to determine the percentage of attendees who use dermoscopy regularly

A Star Trek Approach to Skin Cancer
September 22, 2023

Dermcast.live, Rob Casquejo, PA-C, and Orit Markowitz, MD, dive into the realm of non-invasive techniques for skin cancer diagnosis. Dr. Markowitz emphasizes the advantages of these cutting-edge technologies, highlighting the utility of genetic profiling in the diagnostic process. These innovations offer a plethora of tools for comprehending, prognosticating, and effectively managing skin conditions. As healthcare

Stephen Tyring, MD, discusses Off-label Use of Medications
October 18, 2022

Dermcast.live host Hope Cook, PA-C, engages Dr. Stephen Tyring in an interesting conversation about dermatological conditions for which off-label use of medications are helpful (e.g., warts and autoimmune blistering diseases). Dr. Tyring also guides listeners through situations in which off-label use is the only reasonable choice (e.g., no on-label medications exist, insurance does not cover

Pediatric Dermatology with Lisa Swanson, MD

Pediatric dermatologists pride themselves on being excellent clinical diagnosticians, Dr. Lisa Swanson stated during an Dermcast.live interview hosted by Rob Casquejo, PA-C.  “We really try to figure it out based on the clues, the history, the way the rash presents or the way the spot looks,” she said. “But sometimes, we do have to biopsy”,

Skin Cancer: An Update on Non-Melanoma and Melanoma with Travis Vandergriff, MD
June 28, 2022

SDPA Summer Conference Medical Director Travis Vandergriff, MD, reviewed the epidemiology of melanoma in a lecture focused on melanoma and non-melanoma in U.S. patients. Melanoma is the fifth most diagnosed cancer in people in the US with the highest incidence among non-Hispanic white males and the lowest incidence among black women. A review of data